Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Nat Biotechnol ; 42(4): 591-596, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-37349523

RESUMEN

Current N6-methyladenosine (m6A) mapping methods need large amounts of RNA or are limited to cultured cells. Through optimized sample recovery and signal-to-noise ratio, we developed picogram-scale m6A RNA immunoprecipitation and sequencing (picoMeRIP-seq) for studying m6A in vivo in single cells and scarce cell types using standard laboratory equipment. We benchmark m6A mapping on titrations of poly(A) RNA and embryonic stem cells and in single zebrafish zygotes, mouse oocytes and embryos.


Asunto(s)
ARN , Pez Cebra , Animales , Ratones , Pez Cebra/genética , Pez Cebra/metabolismo , ARN/genética , ARN Mensajero/genética , Células Madre Embrionarias , Células Cultivadas
2.
Placenta ; 37: 34-44, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26612342

RESUMEN

INTRODUCTION: The stroke prone spontaneously hypertensive rat (SHRSP) is an established model of human cardiovascular risk. We sought to characterise the uteroplacental vascular response to pregnancy in this model and determine whether this is affected by the pre-existing maternal hypertension. METHODS: Doppler ultrasound and myography were utilised to assess uterine artery functional and structural changes pre-pregnancy and at gestational day 18 in SHRSP (untreated and nifedipine treated) and in the normotensive Wistar-Kyoto (WKY) rat. Maternal adaptations to pregnancy were also assessed along with histology and expression of genes involved in oxidative stress in the placenta. RESULTS: SHRSP uterine arteries had a pulsatile blood flow and were significantly smaller (70906 ± 3903 µm(2) vs. 95656 ± 8524 µm(2) cross-sectional area; p < 0.01), had a significant increase in contractile response (57.3 ± 10.5 kPa vs 27.7 ± 1.9 kPa; p < 0.01) and exhibited impaired endothelium-dependent vasorelaxation (58.0 ± 5.9% vs 13.9 ± 4.6%; p < 0.01) compared to WKY. Despite significant blood pressure lowering, nifedipine did not improve uterine artery remodelling, function or blood flow in SHRSP. Maternal plasma sFLT-1/PlGF ratio (5.3 ± 0.3 vs 4.6 ± 0.1; p < 0.01) and the urinary albumin/creatinine ratio (1.9 ± 0.2 vs 0.6 ± 0.1; p < 0.01) was increased in SHRSP vs WKY. The SHRSP placenta had a significant reduction in glycogen cell content and an increase in Hif1α, Sod1 and Vegf. DISCUSSION: We conclude that the SHRSP exhibits a number of promising characteristics as a model of spontaneous deficient uteroplacental remodelling that adversely affect pregnancy outcome, independent of pre-existing hypertension.


Asunto(s)
Hipertensión/patología , Complicaciones Cardiovasculares del Embarazo/patología , Accidente Cerebrovascular/patología , Arteria Uterina/patología , Animales , Antihipertensivos/uso terapéutico , Presión Sanguínea/efectos de los fármacos , Femenino , Edad Gestacional , Hipertensión/complicaciones , Hipertensión/tratamiento farmacológico , Nifedipino/uso terapéutico , Embarazo , Complicaciones Cardiovasculares del Embarazo/tratamiento farmacológico , Complicaciones Cardiovasculares del Embarazo/fisiopatología , Ratas , Ratas Endogámicas SHR , Ratas Endogámicas WKY , Factores de Riesgo , Accidente Cerebrovascular/etiología , Accidente Cerebrovascular/fisiopatología , Arteria Uterina/efectos de los fármacos , Arteria Uterina/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA